Clinical Trial Update: Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating obinutuzumab in combination with bendamustine for mature B-cell lymphoma; currently recruiting in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• Gazyva (Obinutuzumab)
• Treanda (Bendamustine)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: B Cell Lymphoma | Phase 2 | Status: RECRUITING